Atosiban
Formulation (FDF) · 0.9 ml:6.75mg; 5 ml:37.5 mg
Formulation (FDF)Confidentiality：Public
- INN / Generic Name
- Atosiban
- Dosage Form
- —
- Strength
- 0.9 ml:6.75mg; 5 ml:37.5 mg
- Therapy Area
- Others > Women's Health
- Indication
- Preterm labour; In vitro fertilisation procedure; Embryo transfer
- Current Status
- Official FDF licensing catalog (UB502)
- GMP Certification
- CN - NMPA
- CEP
- No
- DMF Type
- —
- Stability Data
- —
- BE Required
- Not required / waivable
- Registration Pathway
- Registered (market rights transferable / DCP·NP per market)
- MOQ
- On request
- Lead Time
- On request
- Price Range
- On request
HS Code
3002.15
Registrable Markets
China
Process / Sequence / Exact Price
- Process Summary
- —
- Exact Price